Skip to Main ContentSkip to FooterSkip to Search
Main menu
  1. Home
  2.  » 
  3. Expert Content
  4.  » 
  5. Oral Technologies
  6.  » OptiGel Bio Enables Delivery of Synthetic Oligosaccharides
Icon of a document with a magnifying glass

OptiGel® Bio Technology Enables Oral Delivery of Synthetic Oligosaccharides

Summary: When oral bioavailability is increased, macromolecules can potentially be converted from injectable to oral drug delivery. This case study demonstrates how OptiGel® Bio technology significantly increases oral bioavailability of a synthetic oligosaccharide, thus enabling oral conversion.

Click here to download